MDxHealth is a multinational healthcare company that provides actionable genomic information to personalize the diagnosis and treatment of cancer. The increased adoption of our ConfirmMDx and SelectMDx for Prostate Cancer testing solutions within the U.S. urology community has established MDxHealth as a market leader in the important and growing field of molecular diagnostics.

Working With MDxHealth

MDxHealth seeks talented people who are passionate about improving the diagnosis and treatment of cancer patients.

MDxHealth’s molecular diagnostic solutions address a significant unmet medical need for timely, actionable information that can aid in the reduction of unnecessary biopsies.

MDxHealth’s proprietary, accurate and scalable molecular diagnostic technologies provide a key competitive advantage in the diagnosis, prognosis and management of cancer. In addition to our ongoing and planned studies to expand the clinical utility of our tests, our product pipeline includes tests for bladder, kidney and other urologic cancers. For other cancer types, we have engaged partners to commercialize our epigenetic technologies, as shown by the successful launches of Cologuard® for colon cancer by licensee Exact Sciences and PredictMDx® for Glioblastoma by licensee Laboratory Corporation of America (Labcorp).

MDxHealth currently offers laboratory solutions from a state-of-the-art, 13,444 square foot, College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments of 1988 (CLIA) accredited molecular diagnostics laboratory located at the U.S. headquarters in Irvine, California. The European corporate headquarters is located in Herstal, Belgium and our NXTGNT (Epi)genomics research joint-venture with Ghent University is located in Ghent, Belgium.


Michael K. McGarrity

Chief Executive Officer, Director

Ron Kalfus

Chief Financial Officer

John Bellano

Chief Commercial Officer

Miriam Reyes

Executive Vice President of Operations

Joseph Sollee

Executive Vice President of Corporate Development and General Counsel

Board of Directors

Koen Hoffman

Chairman and Independent Director

Eric Bednarski, Ph.D


Rudi Mariën

Director, representing Biovest CVA

Michael K. McGarrity

Chief Executive Officer, Director

Jan Pensaert

Director, representing Valiance Advisors LLP

Regine Slagmulder

Independent Director, representing Regine Slagmulder BV

Timothy I. Still

Independent Director, representing TSTILL Enterprises LLC

Lieve Verplancke MD.

Independent Director, representing Qaly-Co BVBA

Hilde Windels

Independent Director, representing Hilde Windels BVBA

Clinical Research Network

MDxHealth collaborates with a large number of international academic institutes, medical centers and organizations:

Licensure & Accreditations

MDxHealth endeavors to meet and exceed industry standards for clinical laboratory testing.


MDxHealth seeks talented people who are passionate about improving the diagnosis and treatment of cancer patients.

Contact Us

Please contact us with questions or to learn more about our molecular diagnostic solutions and the real-world studies that prove their effectiveness.